Dofetilide (Mayne Pharma Inc.)


Welcome to the PulseAid listing for the Dofetilide drug offered from Mayne Pharma Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mayne Pharma Inc.
NON-PROPRIETARY NAME: Dofetilide
SUBSTANCE NAME: DOFETILIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-06-07
END MARKETING DATE: 0000-00-00


Dofetilide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDofetilide from Mayne Pharma Inc.
LABELER NAME: Mayne Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2016-06-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51862-005_9ef855ed-9897-4d05-9490-29a004a2e026
PRODUCT NDC: 51862-005
APPLICATION NUMBER: ANDA207058

Other DOFETILIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalTikosyn
Greenstone LLCDofetilide
Mayne Pharma Inc.Dofetilide
Pfizer Laboratories Div Pfizer IncTikosyn